Pathophysiology of Septic Shock.

Area of Science:

• Critical Care Medicine
• Cardiovascular Physiology
• Sepsis Pathophysiology

Background:

• Septic shock is characterized by vasodilation, increased vascular permeability, hypovolemia, and cardiac dysfunction.
• These pathophysiological changes contribute to organ hypoperfusion and failure.
• Understanding the molecular pathways involved is crucial for developing targeted therapies.

Purpose of the Study:

• To review the fundamental features of septic shock.
• To discuss current and potential therapeutic targets for managing septic shock.
• To highlight novel agents for heart rate management in septic shock.

Main Methods:

• Literature review of septic shock pathophysiology and treatment strategies.
• Analysis of molecular pathways implicated in increased vascular permeability.
• Evaluation of pharmacological interventions for vasodilation, hypovolemia, and cardiac dysfunction.

Main Results:

• Vasodilation is primarily treated with vasopressors like norepinephrine.
• Increased vascular permeability involves multiple pathways (e.g., VEGF, angiopoietin/Tie2) offering therapeutic targets.
• Hypovolemia management includes crystalloid fluid resuscitation; cardiac dysfunction may require dobutamine or heart rate reduction with esmolol or ivabradine.

Conclusions:

• Septic shock management requires addressing its core features: vasodilation, increased permeability, hypovolemia, and cardiac dysfunction.
• Targeting specific molecular pathways may offer novel therapeutic avenues.
• Selective heart rate reduction with agents like ivabradine presents a promising strategy without compromising contractility.